Enfusion Management
Management criteria checks 4/4
Enfusion's CEO is Oleg Movchan, appointed in Aug 2022, has a tenure of 2.33 years. total yearly compensation is $1.46M, comprised of 44.7% salary and 55.3% bonuses, including company stock and options. directly owns 1.24% of the company’s shares, worth $16.89M. The average tenure of the management team and the board of directors is 2.2 years and 3.5 years respectively.
Key information
Oleg Movchan
Chief executive officer
US$1.5m
Total compensation
| CEO salary percentage | 44.7% |
| CEO tenure | 2.3yrs |
| CEO ownership | 1.2% |
| Management average tenure | 2.2yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
Is There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?
Nov 23
Why Private Equity Will Buyout Enfusion
Oct 29Enfusion: Growth Should Accelerate In Coming Quarters
Aug 19Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality
Aug 14Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating
Jun 16Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?
Mar 13Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal
Feb 19Enfusion: Product Is Sticky And Industry Is Huge
Jan 18Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)
Jan 04Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%
Dec 02Enfusion: Still Bullish Considering Q3 EBITDA Beat
Nov 08Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching
Oct 31Enfusion Faces Cross-Currents In Investment Management Software Market
Aug 24Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 11Enfusion: Multiple Catalysts
Jun 20Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 08Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation
Feb 08Enfusion brings on Shift4 Payments' Brad Herring as CFO
Dec 19Enfusion Expands Offerings As Revenue Growth Decelerates
Oct 31Enfusion, Inc. (NYSE:ENFN) Shares Could Be 49% Below Their Intrinsic Value Estimate
Oct 18Enfusion gains after takeover report
Aug 31Enfusion gets new interim CEO
Aug 22Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation
Aug 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3m |
| Jun 30 2024 | n/a | n/a | US$3m |
| Mar 31 2024 | n/a | n/a | US$2m |
| Dec 31 2023 | US$1m | US$650k | US$6m |
| Sep 30 2023 | n/a | n/a | US$6m |
| Jun 30 2023 | n/a | n/a | US$6m |
| Mar 31 2023 | n/a | n/a | US$3m |
| Dec 31 2022 | US$2m | US$236k | -US$9m |
Compensation vs Market: Oleg's total compensation ($USD1.46M) is below average for companies of similar size in the US market ($USD5.54M).
Compensation vs Earnings: Oleg's compensation has been consistent with company performance over the past year.
CEO
Oleg Movchan (50 yo)
2.3yrs
Tenure
US$1,455,190
Compensation
Mr. Oleg Movchan has been a Non-Executive Director at Enfusion, Inc since 2021 and a Member of the Board of Managers of Enfusion Ltd. LLC since February 2009. He served as an Interim Chief Executive Office...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.3yrs | US$1.46m | 1.24% $ 16.9m | |
| Chief Financial Officer | 2yrs | US$1.11m | 0.018% $ 241.8k | |
| Chief Operating Officer | 1.1yrs | US$3.04m | 0.12% $ 1.6m | |
| Managing Partner | no data | no data | 1.06% $ 14.5m | |
| Chief Accounting Officer | less than a year | no data | 0.010% $ 136.7k | |
| Chief Technology Officer | less than a year | no data | 0.13% $ 1.8m | |
| Head of Investor Relations | no data | no data | no data | |
| General Counsel & Corporate Secretary | 2.1yrs | no data | 0.018% $ 241.0k | |
| Chief People Officer | 3.2yrs | US$1.86m | 0.053% $ 720.1k | |
| Global Head of Managed Services Production | 3.7yrs | no data | no data | |
| Head of Implementation | 3.7yrs | no data | no data | |
| Head of Client Support | 3.7yrs | no data | no data |
2.2yrs
Average Tenure
50yo
Average Age
Experienced Management: ENFN's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.9yrs | US$1.46m | 1.24% $ 16.9m | |
| Independent Non-Executive Director | 3.9yrs | no data | 1.21% $ 16.6m | |
| Independent Non-Executive Director | 3.9yrs | US$228.17k | 0.17% $ 2.3m | |
| Independent Director | 1.9yrs | US$462.87k | 0.019% $ 264.9k | |
| Independent Non-Executive Director | 3yrs | US$228.17k | 0.044% $ 604.1k | |
| Independent Non-Executive Director | 3yrs | US$234.67k | 0.043% $ 590.6k | |
| Independent Non-Executive Director | 3.9yrs | no data | no data | |
| Independent Chairman | 1.9yrs | US$658.20k | 0.030% $ 404.5k |
3.5yrs
Average Tenure
57.5yo
Average Age
Experienced Board: ENFN's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 10:13 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Enfusion, Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Koji Ikeda | BofA Global Research |
| Kevin McVeigh | Credit Suisse |
| Parth Talsania | Equisights |